Medical Devices Reimbursement Market, By Claims (Underpaid and Full Paid), By Application, By Service Provider, By Reimbursement Model, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV1397
|
Published Date
July 2026
|
Pages
403
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Medical Devices Reimbursement Market size was valued at US$ 789,897.12 Million in 2025, expanding at a CAGR of 7.2% from 2026 to 2033.
Medical device reimbursement refers to the process through which healthcare payers, including government-funded programs and private insurance providers, compensate healthcare providers, hospitals, and patients for the cost of medical devices and related procedures. Reimbursement decisions are typically based on evaluations of clinical effectiveness, patient safety, medical necessity, health outcomes, and cost-effectiveness. The process is influenced by various factors, including coverage policies, medical coding systems such as Current Procedural Terminology (CPT), Healthcare Common Procedure Coding System (HCPCS), International Classification of Diseases (ICD), and Diagnosis-Related Groups (DRGs), as well as payment models and regulatory guidelines established by healthcare authorities and health technology assessment organizations.
Government healthcare expenditure and expanding access to advanced medical technologies are key factors shaping the global medical device reimbursement landscape. According to the World Health Organization (WHO), countries worldwide continue to increase healthcare investments to improve access to essential medical services, diagnostics, and treatment technologies. As healthcare systems focus on value-based care and cost optimization, reimbursement frameworks are increasingly emphasizing evidence-based evaluation, affordability, and improved patient outcomes. These trends are encouraging medical device manufacturers to generate clinical evidence, demonstrate economic value, and align their products with evolving reimbursement requirements across global markets.
Medical Devices Reimbursement Market- Market Dynamics
Increasing Adoption of Advanced Medical Devices Driving Market Growth
The increasing adoption of advanced medical devices is a major factor driving the growth of the medical device reimbursement market, as healthcare providers continue to integrate innovative technologies to improve diagnostic accuracy, treatment effectiveness, and overall patient care. The growing use of cardiac devices, orthopedic implants, robotic-assisted surgical systems, advanced diagnostic imaging equipment, minimally invasive surgical technologies, remote patient monitoring solutions, and wearable medical devices is creating a greater need for comprehensive and sustainable reimbursement frameworks.
Since the acquisition and utilization of advanced medical devices often involve significant costs associated with equipment, procedures, maintenance, and follow-up care, favorable reimbursement policies from government healthcare programs and private insurers play a critical role in improving patient access and supporting wider adoption. To demonstrate the clinical value and economic benefits of their products, medical device manufacturers are increasingly investing in clinical studies, health economics and outcomes research (HEOR), and real-world evidence generation to support reimbursement approvals and market adoption.
Medical Devices Reimbursement Market- Segmentation Analysis:
The Global Medical Devices Reimbursement Market is segmented on the basis of Claims, Application, Service Provider, Reimbursement Model, and Region.
The medical device reimbursement market is segmented based on claims into underpaid and full-paid categories. Among these, the underpaid claims segment holds a significant market share due to the increasing occurrence of reimbursement discrepancies faced by healthcare providers and medical device companies. Underpaid claims occur when healthcare organizations receive lower reimbursement amounts than expected for medical device-related procedures due to factors such as coding errors, changes in reimbursement policies, documentation issues, and administrative challenges. These discrepancies can create financial pressure for hospitals, clinics, and manufacturers, while also increasing disputes between healthcare providers and insurance companies. Recovering lost revenue from underpaid claims can be challenging due to complex verification processes and lengthy appeal procedures. In markets such as the United States, variations in medical coding practices and frequent updates to insurance policies continue to contribute to reimbursement challenges for medical device claims, highlighting the need for advanced claims management and reimbursement optimization solutions.
Based on application, the medical device reimbursement market is categorized into public payers and private payers. The public payer segment is expected to hold a significant market share, driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing demand for affordable and accessible treatment options. Government-funded healthcare programs play a crucial role in expanding patient access to advanced medical technologies, particularly as innovative medical devices become more widely adopted across developed and emerging economies. The availability of reimbursement pathways for new technologies is further supporting segment growth. For example, in July 2024, the Centers for Medicare & Medicaid Services (CMS) introduced the Transitional Coverage for Emerging Technologies (TCET) pathway to provide faster Medicare coverage consideration for FDA-designated breakthrough medical devices, supporting timely patient access to innovative healthcare solutions.
Medical Devices Reimbursement Market- Geographical Insights
North America holds a dominant position in the medical device reimbursement market, supported by its well-established healthcare infrastructure, high insurance coverage rates, and advanced reimbursement frameworks for innovative medical technologies. The region benefits from comprehensive public and private healthcare payment systems, including Medicare and Medicaid in the United States, which facilitate broader adoption of advanced medical devices across hospitals, ambulatory surgery centers, and home healthcare settings. Favorable government reimbursement policies aimed at improving access to emerging technologies are further contributing to market growth. For example, the Centers for Medicare & Medicaid Services (CMS) continues to enhance reimbursement initiatives such as the New Technology Add-on Payment (NTAP) program, which provides additional Medicare payments for eligible innovative technologies demonstrating substantial clinical benefits.
Government healthcare expenditure trends further highlight the strong growth potential of the North American market. According to CMS data, U.S. National Health Expenditures (NHE) increased by approximately 7.2% to reach USD 5.3 trillion in 2024. During the same period, Medicare spending grew by 7.8% to USD 1.118 trillion, Medicaid spending increased by 6.6% to USD 931.7 billion, and private health insurance expenditure rose by 8.8% to USD 1.645 trillion. The continued expansion of healthcare spending, combined with supportive reimbursement policies and increasing adoption of advanced medical technologies, is expected to strengthen the region’s position in the medical device reimbursement market.
US Medical Devices Reimbursement Market- Country Insights
The United States accounts for a significant share of the medical device reimbursement market, driven by its advanced healthcare infrastructure, well-established reimbursement framework, and rapid adoption of innovative medical technologies. The country has a comprehensive healthcare payment ecosystem supported by major public payer programs, including Medicare and Medicaid, along with extensive private insurance coverage that facilitates reimbursement for a wide range of diagnostic, therapeutic, and implantable medical devices.
Market growth in the US is further supported by the rising prevalence of chronic diseases, an aging population, and increasing demand for advanced healthcare solutions such as minimally invasive procedures, robotic-assisted surgeries, cardiac devices, orthopedic implants, and advanced diagnostic imaging technologies. As healthcare providers continue to adopt next-generation medical devices to improve patient outcomes and operational efficiency, the need for effective reimbursement pathways is expected to remain a key factor supporting market expansion.
Medical Devices Reimbursement Market- Competitive Landscape:
The medical device reimbursement market is highly competitive and service-oriented, with participation from reimbursement consulting firms, healthcare analytics providers, contract research organizations (CROs), health economics and outcomes research (HEOR) consultants, medical device manufacturers, and public and private healthcare payers. Market participants compete by offering comprehensive reimbursement and market access services, including medical coding support, coverage and payment strategy development, health technology assessment (HTA) consulting, real-world evidence generation, value dossier preparation, payer engagement, and claims management. As reimbursement regulations become increasingly complex and healthcare systems shift toward value-based care, companies are expanding their expertise in reimbursement strategy, evidence generation, and market access consulting to help manufacturers accelerate product adoption and secure favorable coverage decisions.
To strengthen their competitive position, organizations are investing in digital reimbursement platforms, advanced healthcare analytics, regulatory advisory services, and data-driven evidence generation to support reimbursement approvals across global markets. Strategic collaborations with healthcare providers, payers, and regulatory agencies are also becoming increasingly important as companies seek to improve patient access to innovative medical technologies while demonstrating their clinical and economic value.
Recent Developments:
- In August 2025, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination (NCD) providing reimbursement for Implantable Pulmonary Artery Pressure Sensors (IPAPS) used in the management of heart failure under the Coverage with Evidence Development (CED) framework. As part of this decision, the CardioMEMS CED study received CMS approval, expanding Medicare beneficiary access to the CardioMEMS HF System for eligible patients who meet the established coverage criteria.
- In February 2025, the French National Authority for Health released seven recommendations concerning the add-on reimbursement of medical devices and medical aids. Developed by the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS), the recommendations addressed the inclusion and modification of products within France’s List of Reimbursable Products and Services (LPPR), covering medical technologies across neurovascular care, neuromodulation, endocrinology, ophthalmology, orthopedics, and other therapeutic areas.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- UnitedHealth Group
- CVS Health
- The Cigna Group
- Humana
- Elevance Health
- Centene Corporation
- MCRA
- IQVIA
- BNP Paribas
- Allianz
- Aviva
- WellCare Health Plans
- Abbott Laboratories
- Boston Scientific
- Medtronic
- Johnson & Johnson MedTech
- BD
- Stryker
- Siemens Healthineers
- AdvaMed
- Others
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY CLAIMS- MARKET ANALYSIS, 2020 - 2033
- Underpaid
- Full Paid
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Public Payers
- Private Payers
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY SERVICE PROVIDER- MARKET ANALYSIS, 2020 - 2033
- Physician Office
- Diagnostic Laboratories
- Hospitals
- Others
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY REIMBURSEMENT MODEL- MARKET ANALYSIS, 2020 - 2033
- Fee-for-Service
- Bundled Payments
- Capitation
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Medical Devices Reimbursement Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Medical Devices Reimbursement Market Snippet by Claims
2.1.2. Medical Devices Reimbursement Market Snippet by Application
2.1.3. Medical Devices Reimbursement Market Snippet by Service Provider
2.1.4. Medical Devices Reimbursement Market Snippet by Reimbursement Model
2.1.5. Medical Devices Reimbursement Market Snippet by Country
2.1.6. Medical Devices Reimbursement Market Snippet by Region
2.2. Competitive Insights
3. Medical Devices Reimbursement Key Market Trends
3.1. Medical Devices Reimbursement Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Medical Devices Reimbursement Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Medical Devices Reimbursement Market Opportunities
3.4. Medical Devices Reimbursement Market Future Trends
4. Medical Devices Reimbursement Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Medical Devices Reimbursement Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Medical Devices Reimbursement Market Landscape
6.1. Medical Devices Reimbursement Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Medical Devices Reimbursement Market – By Claims
7.1. Overview
7.1.1. Segment Share Analysis, By Claims, 2025 & 2033 (%)
7.1.2. Underpaid
7.1.3. Full Paid
8. Medical Devices Reimbursement Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Public Payers
8.1.3. Private Payers
9. Medical Devices Reimbursement Market – By Service Provider
9.1. Overview
9.1.1. Segment Share Analysis, By Service Provider, 2025 & 2033 (%)
9.1.2. Physician Office
9.1.3. Diagnostic Laboratories
9.1.4. Hospitals
9.1.5. Others
10. Medical Devices Reimbursement Market – By Reimbursement Model
10.1. Overview
10.1.1. Segment Share Analysis, By Reimbursement Model, 2025 & 2033 (%)
10.1.2. Fee-for-Service
10.1.3. Bundled Payments
10.1.4. Capitation
11. Medical Devices Reimbursement Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Medical Devices Reimbursement Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Medical Devices Reimbursement Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Medical Devices Reimbursement Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Medical Devices Reimbursement Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Medical Devices Reimbursement Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Claims, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Service Provider, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By Reimbursement Model, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Medical Devices Reimbursement Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. UnitedHealth Group
12.2.2. CVS Health
12.2.3. The Cigna Group
12.2.4. Humana
12.2.5. Elevance Health
12.2.6. Centene Corporation
12.2.7. MCRA
12.2.8. IQVIA
12.2.9. BNP Paribas
12.2.10. Allianz
12.2.11. Aviva
12.2.12. WellCare Health Plans
12.2.13. Abbott Laboratories
12.2.14. Boston Scientific
12.2.15. Medtronic
12.2.16. Johnson & Johnson MedTech
12.2.17. BD
12.2.18. Stryker
12.2.19. Siemens Healthineers
12.2.20. AdvaMed
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- UnitedHealth Group
- CVS Health
- The Cigna Group
- Humana
- Elevance Health
- Centene Corporation
- MCRA
- IQVIA
- BNP Paribas
- Allianz
- Aviva
- WellCare Health Plans
- Abbott Laboratories
- Boston Scientific
- Medtronic
- Johnson & Johnson MedTech
- BD
- Stryker
- Siemens Healthineers
- AdvaMed
- Others
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY CLAIMS- MARKET ANALYSIS, 2020 - 2033
- Underpaid
- Full Paid
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Public Payers
- Private Payers
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY SERVICE PROVIDER- MARKET ANALYSIS, 2020 - 2033
- Physician Office
- Diagnostic Laboratories
- Hospitals
- Others
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY REIMBURSEMENT MODEL- MARKET ANALYSIS, 2020 - 2033
- Fee-for-Service
- Bundled Payments
- Capitation
GLOBAL MEDICAL DEVICES REIMBURSEMENT MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
